Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 105

1.

Single-cell heterogeneity in Sézary syndrome.

Buus TB, Willerslev-Olsen A, Fredholm S, Blümel E, Nastasi C, Gluud M, Hu T, Lindahl LM, Iversen L, Fogh H, Gniadecki R, Litvinov IV, Persson JL, Bonefeld CM, Geisler C, Christensen JP, Krejsgaard T, Litman T, Woetmann A, Ødum N.

Blood Adv. 2018 Aug 28;2(16):2115-2126. doi: 10.1182/bloodadvances.2018022608.

2.

Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.

Lindahl LM, Besenbacher S, Rittig AH, Celis P, Willerslev-Olsen A, Gjerdrum LMR, Krejsgaard T, Johansen C, Litman T, Woetmann A, Odum N, Iversen L.

Blood. 2018 Feb 15;131(7):759-770. doi: 10.1182/blood-2017-06-788950. Epub 2017 Dec 5.

PMID:
29208599
3.

Effects of glucocorticoids on stratum corneum lipids and function in human skin-A detailed lipidomic analysis.

Røpke MA, Alonso C, Jung S, Norsgaard H, Richter C, Darvin ME, Litman T, Vogt A, Lademann J, Blume-Peytavi U, Kottner J.

J Dermatol Sci. 2017 Dec;88(3):330-338. doi: 10.1016/j.jdermsci.2017.08.009. Epub 2017 Aug 26.

PMID:
28911799
4.

The gene expression and immunohistochemical time-course of diphenylcyclopropenone-induced contact allergy in healthy humans following repeated epicutaneous challenges.

Mose KF, Burton M, Thomassen M, Andersen F, Kruse TA, Tan Q, Skov L, Røpke MA, Litman T, Clemmensen O, Kristensen BW, Friedmann PS, Andersen KE.

Exp Dermatol. 2017 Oct;26(10):926-933. doi: 10.1111/exd.13345. Epub 2017 Jul 9.

PMID:
28370374
5.

The immunoglobulin superfamily member CD200R identifies cells involved in type 2 immune responses.

Blom LH, Martel BC, Larsen LF, Hansen CV, Christensen MP, Juel-Berg N, Litman T, Poulsen LK.

Allergy. 2017 Jul;72(7):1081-1090. doi: 10.1111/all.13129. Epub 2017 Feb 21.

PMID:
28106273
6.

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Payabyab EC, Balasubramaniam S, Edgerly M, Velarde M, Merino MJ, Venkatesan AM, Leuva H, Litman T, Bates SE, Fojo T.

Clin Cancer Res. 2016 Oct 15;22(20):4989-5000.

7.

Major differences between human atopic dermatitis and murine models, as determined by using global transcriptomic profiling.

Ewald DA, Noda S, Oliva M, Litman T, Nakajima S, Li X, Xu H, Workman CT, Scheipers P, Svitacheva N, Labuda T, Krueger JG, Suárez-Fariñas M, Kabashima K, Guttman-Yassky E.

J Allergy Clin Immunol. 2017 Feb;139(2):562-571. doi: 10.1016/j.jaci.2016.08.029. Epub 2016 Oct 1.

PMID:
27702671
8.

Tumor-Preferential Induction of Immune Responses and Epidermal Cell Death in Actinic Keratoses by Ingenol Mebutate.

Emmert S, Haenssle HA, Zibert JR, Schön M, Hald A, Hansen MH, Litman T, Schön MP.

PLoS One. 2016 Sep 9;11(9):e0160096. doi: 10.1371/journal.pone.0160096. eCollection 2016.

9.

Repeated monthly epicutaneous challenges with diphenylcyclopropenone result in a clinically reproducible level of contact allergy in de novo sensitized individuals.

Mose KF, Andersen F, Skov L, Røpke MA, Litman T, Friedmann PS, Andersen KE.

Br J Dermatol. 2017 Apr;176(4):1095-1097. doi: 10.1111/bjd.14949. Epub 2017 Feb 7. No abstract available.

PMID:
27515376
10.

Distinct molecular signatures of mild extrinsic and intrinsic atopic dermatitis.

Martel BC, Litman T, Hald A, Norsgaard H, Lovato P, Dyring-Andersen B, Skov L, Thestrup-Pedersen K, Skov S, Skak K, Poulsen LK.

Exp Dermatol. 2016 Jun;25(6):453-9. doi: 10.1111/exd.12967. Epub 2016 Feb 26.

PMID:
26841714
11.

The effect of short-chain fatty acids on human monocyte-derived dendritic cells.

Nastasi C, Candela M, Bonefeld CM, Geisler C, Hansen M, Krejsgaard T, Biagi E, Andersen MH, Brigidi P, Ødum N, Litman T, Woetmann A.

Sci Rep. 2015 Nov 6;5:16148. doi: 10.1038/srep16148.

12.

Meta-analysis derived atopic dermatitis (MADAD) transcriptome defines a robust AD signature highlighting the involvement of atherosclerosis and lipid metabolism pathways.

Ewald DA, Malajian D, Krueger JG, Workman CT, Wang T, Tian S, Litman T, Guttman-Yassky E, Suárez-Fariñas M.

BMC Med Genomics. 2015 Oct 12;8:60. doi: 10.1186/s12920-015-0133-x.

13.

miR-155, identified as anti-metastatic by global miRNA profiling of a metastasis model, inhibits cancer cell extravasation and colonization in vivo and causes significant signaling alterations.

Thomsen KG, Terp MG, Lund RR, Søkilde R, Elias D, Bak M, Litman T, Beck HC, Lyng MB, Ditzel HJ.

Oncotarget. 2015 Oct 6;6(30):29224-39. doi: 10.18632/oncotarget.4942.

14.

Romidepsin in peripheral and cutaneous T-cell lymphoma: mechanistic implications from clinical and correlative data.

Bates SE, Eisch R, Ling A, Rosing D, Turner M, Pittaluga S, Prince HM, Kirschbaum MH, Allen SL, Zain J, Geskin LJ, Joske D, Popplewell L, Cowen EW, Jaffe ES, Nichols J, Kennedy S, Steinberg SM, Liewehr DJ, Showe LC, Steakley C, Wright J, Fojo T, Litman T, Piekarz RL.

Br J Haematol. 2015 Jul;170(1):96-109. doi: 10.1111/bjh.13400. Epub 2015 Apr 19.

15.

Kinetics of gene expression and bone remodelling in the clinical phase of collagen-induced arthritis.

Denninger KC, Litman T, Marstrand T, Moller K, Svensson L, Labuda T, Andersson Å.

Arthritis Res Ther. 2015 Mar 5;17:43. doi: 10.1186/s13075-015-0531-7.

16.

Identification of novel immune and barrier genes in atopic dermatitis by means of laser capture microdissection.

Esaki H, Ewald DA, Ungar B, Rozenblit M, Zheng X, Xu H, Estrada YD, Peng X, Mitsui H, Litman T, Suárez-Fariñas M, Krueger JG, Guttman-Yassky E.

J Allergy Clin Immunol. 2015 Jan;135(1):153-63. doi: 10.1016/j.jaci.2014.10.037.

17.

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.

Ralfkiaer U, Lindahl LM, Litman T, Gjerdrum LM, Ahler CB, Gniadecki R, Marstrand T, Fredholm S, Iversen L, Wasik MA, Bonefeld CM, Geisler C, Krejsgaard T, Glue C, Røpke MA, Woetmann A, Skov L, Grønbæk K, Odum N.

Anticancer Res. 2014 Dec;34(12):7207-17. Erratum in: Anticancer Res. 2015 Feb;35(2):1219. Lindal, Lise [corrected to Lindahl, Lise M].

PMID:
25503151
18.

Glucose tolerance is associated with differential expression of microRNAs in skeletal muscle: results from studies of twins with and without type 2 diabetes.

Bork-Jensen J, Scheele C, Christophersen DV, Nilsson E, Friedrichsen M, Fernandez-Twinn DS, Grunnet LG, Litman T, Holmstrøm K, Vind B, Højlund K, Beck-Nielsen H, Wojtaszewski J, Ozanne SE, Pedersen BK, Poulsen P, Vaag A.

Diabetologia. 2015 Feb;58(2):363-73. doi: 10.1007/s00125-014-3434-2. Epub 2014 Nov 19.

19.

Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Rask L, Balslev E, Søkilde R, Høgdall E, Flyger H, Eriksen J, Litman T.

Cell Oncol (Dordr). 2014 Jun;37(3):215-27. doi: 10.1007/s13402-014-0176-6. Epub 2014 Jul 16.

PMID:
25027758
20.

Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.

Luchenko VL, Litman T, Chakraborty AR, Heffner A, Devor C, Wilkerson J, Stein W, Robey RW, Bangiolo L, Levens D, Bates SE.

Mol Oncol. 2014 Dec;8(8):1379-92. doi: 10.1016/j.molonc.2014.05.001. Epub 2014 May 28.

21.

Efficient identification of miRNAs for classification of tumor origin.

Søkilde R, Vincent M, Møller AK, Hansen A, Høiby PE, Blondal T, Nielsen BS, Daugaard G, Møller S, Litman T.

J Mol Diagn. 2014 Jan;16(1):106-15. doi: 10.1016/j.jmoldx.2013.10.001. Epub 2013 Nov 5.

PMID:
24211363
22.

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas.

Marstrand T, Ahler CB, Ralfkiaer U, Clemmensen A, Kopp KL, Sibbesen NA, Krejsgaard T, Litman T, Wasik MA, Bonefeld CM, Grønbæk K, Gjerdum LM, Gniadecki R, Ralfkiaer E, Geisler C, Woetmann A, Røpke MA, Glue C, Skov L, Odum N.

Leuk Lymphoma. 2014 Apr;55(4):957-8. doi: 10.3109/10428194.2013.815352. Epub 2013 Jul 29. No abstract available.

PMID:
23772646
23.

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma.

Kopp KL, Ralfkiaer U, Gjerdrum LM, Helvad R, Pedersen IH, Litman T, Jønson L, Hagedorn PH, Krejsgaard T, Gniadecki R, Bonefeld CM, Skov L, Geisler C, Wasik MA, Ralfkiaer E, Ødum N, Woetmann A.

Cell Cycle. 2013 Jun 15;12(12):1939-47. doi: 10.4161/cc.24987. Epub 2013 May 15.

24.

Transportation and public health.

Litman T.

Annu Rev Public Health. 2013;34:217-33. doi: 10.1146/annurev-publhealth-031912-114502. Epub 2013 Jan 16. Review.

PMID:
23330699
25.

The rectal cancer microRNAome--microRNA expression in rectal cancer and matched normal mucosa.

Gaedcke J, Grade M, Camps J, Søkilde R, Kaczkowski B, Schetter AJ, Difilippantonio MJ, Harris CC, Ghadimi BM, Møller S, Beissbarth T, Ried T, Litman T.

Clin Cancer Res. 2012 Sep 15;18(18):4919-30. Epub 2012 Jul 31.

26.

Global microRNA expression profiling of high-risk ER+ breast cancers from patients receiving adjuvant tamoxifen mono-therapy: a DBCG study.

Lyng MB, Lænkholm AV, Søkilde R, Gravgaard KH, Litman T, Ditzel HJ.

PLoS One. 2012;7(5):e36170. doi: 10.1371/journal.pone.0036170. Epub 2012 May 18.

27.

The miRNA-200 family and miRNA-9 exhibit differential expression in primary versus corresponding metastatic tissue in breast cancer.

Gravgaard KH, Lyng MB, Laenkholm AV, Søkilde R, Nielsen BS, Litman T, Ditzel HJ.

Breast Cancer Res Treat. 2012 Jul;134(1):207-17. doi: 10.1007/s10549-012-1969-9.

PMID:
22294488
28.

How the RNA isolation method can affect microRNA microarray results.

Podolska A, Kaczkowski B, Litman T, Fredholm M, Cirera S.

Acta Biochim Pol. 2011;58(4):535-40. Epub 2011 Dec 6.

29.

High expression of miR-21 in tumor stroma correlates with increased cancer cell proliferation in human breast cancer.

Rask L, Balslev E, Jørgensen S, Eriksen J, Flyger H, Møller S, Høgdall E, Litman T, Nielsen BS.

APMIS. 2011 Oct;119(10):663-73. doi: 10.1111/j.1600-0463.2011.02782.x. Epub 2011 Jun 17.

PMID:
21917003
30.

MicroRNA expression profiles associated with development of drug resistance in Ehrlich ascites tumor cells.

Husted S, Søkilde R, Rask L, Cirera S, Busk PK, Eriksen J, Litman T.

Mol Pharm. 2011 Dec 5;8(6):2055-62. doi: 10.1021/mp200255d. Epub 2011 Sep 21.

PMID:
21899346
31.

Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL).

Ralfkiaer U, Hagedorn PH, Bangsgaard N, Løvendorf MB, Ahler CB, Svensson L, Kopp KL, Vennegaard MT, Lauenborg B, Zibert JR, Krejsgaard T, Bonefeld CM, Søkilde R, Gjerdrum LM, Labuda T, Mathiesen AM, Grønbæk K, Wasik MA, Sokolowska-Wojdylo M, Queille-Roussel C, Gniadecki R, Ralfkiaer E, Geisler C, Litman T, Woetmann A, Glue C, Røpke MA, Skov L, Odum N.

Blood. 2011 Nov 24;118(22):5891-900. doi: 10.1182/blood-2011-06-358382. Epub 2011 Aug 24.

32.

IFN-α primes T- and NK-cells for IL-15-mediated signaling and cytotoxicity.

Hansen ML, Woetmann A, Krejsgaard T, Kopp KL, Søkilde R, Litman T, Straten PT, Geisler C, Wasik MA, Odum N, Eriksen KW.

Mol Immunol. 2011 Sep;48(15-16):2087-93. doi: 10.1016/j.molimm.2011.07.008. Epub 2011 Aug 2.

PMID:
21813181
33.

Crx broadly modulates the pineal transcriptome.

Rovsing L, Clokie S, Bustos DM, Rohde K, Coon SL, Litman T, Rath MF, Møller M, Klein DC.

J Neurochem. 2011 Oct;119(2):262-74. doi: 10.1111/j.1471-4159.2011.07405.x. Epub 2011 Sep 2.

34.

Diagnostic and prognostic signatures from the small non-coding RNA transcriptome in prostate cancer.

Martens-Uzunova ES, Jalava SE, Dits NF, van Leenders GJ, Møller S, Trapman J, Bangma CH, Litman T, Visakorpi T, Jenster G.

Oncogene. 2012 Feb 23;31(8):978-91. doi: 10.1038/onc.2011.304. Epub 2011 Jul 18.

PMID:
21765474
35.

MicroRNA expression profiling of the porcine developing brain.

Podolska A, Kaczkowski B, Kamp Busk P, Søkilde R, Litman T, Fredholm M, Cirera S.

PLoS One. 2011 Jan 6;6(1):e14494. doi: 10.1371/journal.pone.0014494.

36.

Global microRNA analysis of the NCI-60 cancer cell panel.

Søkilde R, Kaczkowski B, Podolska A, Cirera S, Gorodkin J, Møller S, Litman T.

Mol Cancer Ther. 2011 Mar;10(3):375-84. doi: 10.1158/1535-7163.MCT-10-0605. Epub 2011 Jan 20.

37.

MicroRNAs and potential target interactions in psoriasis.

Zibert JR, Løvendorf MB, Litman T, Olsen J, Kaczkowski B, Skov L.

J Dermatol Sci. 2010 Jun;58(3):177-85. doi: 10.1016/j.jdermsci.2010.03.004. Epub 2010 Mar 17.

PMID:
20417062
38.

Transportation policy and injury control.

Litman TA.

Inj Prev. 2009 Dec;15(6):362-3. doi: 10.1136/ip.2009.024240. No abstract available.

PMID:
19959725
39.

Quantitative miRNA expression analysis: comparing microarrays with next-generation sequencing.

Willenbrock H, Salomon J, Søkilde R, Barken KB, Hansen TN, Nielsen FC, Møller S, Litman T.

RNA. 2009 Nov;15(11):2028-34. doi: 10.1261/rna.1699809. Epub 2009 Sep 10.

40.

Identification and analysis of miRNAs in human breast cancer and teratoma samples using deep sequencing.

Nygaard S, Jacobsen A, Lindow M, Eriksen J, Balslev E, Flyger H, Tolstrup N, Møller S, Krogh A, Litman T.

BMC Med Genomics. 2009 Jun 9;2:35. doi: 10.1186/1755-8794-2-35.

41.

Ammonia and urea permeability of mammalian aquaporins.

Litman T, Søgaard R, Zeuthen T.

Handb Exp Pharmacol. 2009;(190):327-58. doi: 10.1007/978-3-540-79885-9_17. Review.

PMID:
19096786
42.

Differential effects of class I isoform histone deacetylase depletion and enzymatic inhibition by belinostat or valproic acid in HeLa cells.

Dejligbjerg M, Grauslund M, Litman T, Collins L, Qian X, Jeffers M, Lichenstein H, Jensen PB, Sehested M.

Mol Cancer. 2008 Sep 12;7:70. doi: 10.1186/1476-4598-7-70.

43.

Interaction with the 5D3 monoclonal antibody is regulated by intramolecular rearrangements but not by covalent dimer formation of the human ABCG2 multidrug transporter.

Ozvegy-Laczka C, Laczkó R, Hegedus C, Litman T, Várady G, Goda K, Hegedus T, Dokholyan NV, Sorrentino BP, Váradi A, Sarkadi B.

J Biol Chem. 2008 Sep 19;283(38):26059-70. doi: 10.1074/jbc.M803230200. Epub 2008 Jul 21.

44.
45.

PolyHEMA spheroids are an inadequate model for the drug resistance of the intractable solid tumors.

Steadman K, Stein WD, Litman T, Yang SX, Abu-Asab M, Dutcher SK, Bates S.

Cell Cycle. 2008 Mar 15;7(6):818-29. Epub 2008 Jan 9.

PMID:
18239467
46.

A database study that identifies genes whose expression correlates, negatively or positively, with 5-year survival of cancer patients.

Stein WD, Litman T, Fojo T, Bates SE.

Biochim Biophys Acta. 2007 Jun;1770(6):857-71. Epub 2007 Jan 25.

PMID:
17398010
47.
48.

Identification of intra- and intermolecular disulfide bridges in the multidrug resistance transporter ABCG2.

Henriksen U, Fog JU, Litman T, Gether U.

J Biol Chem. 2005 Nov 4;280(44):36926-34. Epub 2005 Aug 17.

49.

Gene expression profiling in chemoresistant variants of three cell lines of different origin.

Johnsson A, Vallon-Christensson J, Strand C, Litman T, Eriksen J.

Anticancer Res. 2005 Jul-Aug;25(4):2661-8.

50.

Localization of the ABCG2 mitoxantrone resistance-associated protein in normal tissues.

Fetsch PA, Abati A, Litman T, Morisaki K, Honjo Y, Mittal K, Bates SE.

Cancer Lett. 2006 Apr 8;235(1):84-92. Epub 2005 Jun 28.

PMID:
15990223

Supplemental Content

Loading ...
Support Center